<?xml version="1.0" encoding="UTF-8"?>
<ref id="CR45">
 <label>45.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Grilo</surname>
    <given-names>AL</given-names>
   </name>
   <name>
    <surname>Mantalaris</surname>
    <given-names>A</given-names>
   </name>
  </person-group>
  <article-title>The Increasingly Human and Profitable Monoclonal Antibody Market</article-title>
  <source>Trends Biotechnol</source>
  <year>2019</year>
  <volume>37</volume>
  <fpage>9</fpage>
  <lpage>16</lpage>
  <pub-id pub-id-type="doi">10.1016/j.tibtech.2018.05.014</pub-id>
  <?supplied-pmid 29945725?>
  <pub-id pub-id-type="pmid">29945725</pub-id>
 </element-citation>
</ref>
